ClearLight Biotechnologies

ClearLight Biotechnologies Overview

Founded 2014
Status Private
Employees 3
Latest Deal Type Early Stage VC
Latest Deal Amount $2.77M
Latest Deal Amount
Investors 6

ClearLight Biotechnologies General Information


Developer of a next generation tissue processing and imaging technology aimed at revolutionizing cancer treatment. The company's technology provides a suite of powerful tools, with deep 3-D imaging, which will allow the measurement of important spatial relationships between different cell types, vasculature and nucleic acids within the tumor and surrounding tissue and provides high-resolution information from solid tumors, while maintaining the global perspective needed to understand the complex tumor microenvironment, enabling better treatment decisions for patients.

Contact Information

Formerly Known As
ClearLight Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 428 Oakmead Parkway
  • Sunnyvale, CA 94085
  • United States
+1 (800) 000-0000

ClearLight Biotechnologies Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ClearLight Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 08-May-2018 $2.77M 00.000 Completed Product Development
2. Early Stage VC (Series B) 03-Oct-2016 00.00 00.000 Completed Startup
1. Early Stage VC (Series A) 08-Oct-2015 $2.58M $2.58M Completed Startup

ClearLight Biotechnologies Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Genomic Expression Venture Capital-Backed Beverly, MA 00 00.00 0000000000 00.00
00000000 Formerly Angel backed Alameda, CA 00 000.00 000000000 000.00
0000000 Venture Capital-Backed Hampton, NJ 0 00000 0000000000 00000
00000000000 000000 Venture Capital-Backed Birmingham, AL 00 00.000 0000000000 0 00.000
000000000 00000000 Venture Capital-Backed Lausanne, Switzerland 00 000.00 00000000000 000.00

ClearLight Biotechnologies Executive Team (4)

Name Title Board Seat Contact Info
Laurie Goodman Ph.D Chief Executive Officer & Board Member
Maria Hurst Director of Operations
Karl Deisseroth Ph.D Founder & Scientific Advisor

1 Former Executive

ClearLight Biotechnologies Board Members (5)

To view ClearLight Biotechnologies‘s full board member team, request access >>
Name Representing Role Since
Albert Hansen KESA Partners Vice Chairman 000 0000
Alexander Wiegers Wiegers Capital Management Chairman 000 0000
Laurie Goodman Ph.D ClearLight Biotechnologies Chief Executive Officer & Board Member 000 0000

2 Former Board Members

ClearLight Biotechnologies Investors (6)

To view ClearLight Biotechnologies‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CS Investors Corporation Minority 000 0000 000000 0
KESA Partners Merchant Banking Firm Minority 000 0000 000000 0
NFLS - Pivotal Venture Capital Minority 000 0000 000000 0
Pivotal Paramount Investment Other Minority 000 0000 000000 0
Stanford University Venture Fund Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial